Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Masanori Shiratori"'
Autor:
Masanori Shiratori, Kimiyuki Ikeda, Mitsuo Otsuka, Hiroki Takahashi, Keiki Yokoo, Hirotaka Nishikiori, Hirofumi Chiba, Yasuaki Umeda, Hiroyuki Koba
Publikováno v:
Pulmonary Research and Respiratory Medicine – Open Journal. 4:24-32
Autor:
Yoshihiro Hasegawa, Keiki Yokoo, Atsushi Saito, Kimiyuki Ikeda, Mitsuo Otsuka, Koji Kuronuma, Hiroki Takahashi, Hirotaka Nishikiori, Masanori Shiratori, Gen Yamada, Hirofumi Chiba
Publikováno v:
Respiratory Medicine. 131:184-191
Background Idiopathic pulmonary fibrosis (IPF) is a fatal pulmonary disease with poor prognosis. Pirfenidone, the first antifibrotic drug, suppresses the decline in forced vital capacity (FVC) and improves prognosis in some, but not all, patients wit
Autor:
Hirofumi Chiba, Masanori Shiratori, Yoshiro Niitsu, Hiroki Takahashi, Yasushi Sato, Mitsuo Otsuka, Koji Kuronuma
Publikováno v:
Experimental Lung Research. 43:271-282
Pulmonary fibrosis is a life-threatening pathological state of progressive interstitial lung diseases, such as idiopathic pulmonary fibrosis. Myofibroblasts are known to play a critical role in the pathogenesis of pulmonary fibrosis. This study aimed
Autor:
Kimiyuki Ikeda, Hiroki Takahashi, Keiki Yokoo, Atsushi Saito, Mitsuo Otsuka, Masanori Shiratori, Yuichiro Asai, Koji Kuronuma, Hirotaka Nishikiori, Youhei Takahashi, Mamoru Takahashi, Gen Yamada, Hirofumi Chiba
Publikováno v:
Diffuse Parenchymal Lung Disease.
Background: Idiopathic pulmonary fibrosis (IPF) is a fatal pulmonary disease with poor prognosis. Pirfenidone, the first antifibrotic drug, suppresses the decline in forced vital capacity (FVC) and improves prognosis in some, but not all, patients wi
Autor:
Hirofumi Chiba, Junya Kitada, Hiroki Takahashi, Kazumi Kudo, Yuichi Yamada, Keiki Yokoo, Hirotaka Nishikiori, Masanori Shiratori, Sin-ichiro Inomata, Gen Yamada, Masaru Fujii
Publikováno v:
The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders. 33:133-137
Autor:
Masaru Hamaoki, Makoto Murata, Masanori Shiratori, Satoshi Kanazawa, Hisato Nagae, Yoshio Kuroki, Mitsuo Otsuka, Hiromi Mizuno, Hiroki Takahashi, Miyazaki Shuichi
Publikováno v:
Experimental Lung Research. 36:463-468
Surfactant protein D (SP-D) has been used as a biomarker of lung inflammation. In rat, several types of enzyme-linked immunosorbent assay (ELISA) using polyclonal antibodies have been reported. The purpose of this study was the development of a sensi
Publikováno v:
Japanese Journal of Ophthalmology. 50:558-561
Publikováno v:
Respirology. 11:330-333
Pulmonary alveolar microlithiasis (PAM) is a rare disease characterized by widespread localization of calcispherites in the alveolar spaces. The authors report two cases of PAM, with markedly elevated sera concentrations of surfactant protein-A and s
Autor:
Hiroki Takahashi, Masanori Shiratori
Publikováno v:
Nihon Naika Gakkai Zasshi. 95:986-992
Autor:
Hiroki Takahashi, Yoshio Kuroki, Hirofumi Chiba, Shosaku Abe, Michio Hirasawa, Orie Yamamoto, Masanori Shiratori
Publikováno v:
Respiratory Medicine. 99:1164-1174
Summary Background Inflow of tumor cells to circulation is an essential step for metastasis of primary tumors. To know its state may contribute to therapeutic strategy. However, methodology to detect lung carcinoma cells floating in peripheral blood